MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
170 hedge funds and large institutions have $2.33B invested in Momenta Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 69 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
73% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 40
10% more funds holding
Funds holding: 154 → 170 (+16)
Holders
170
Holding in Top 10
2
Calls
$5.31M
Puts
$1.15M
Top Buyers
| 1 | +$63.9M | |
| 2 | +$54.3M | |
| 3 | +$50.3M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$35.3M |
| 5 |
BlackRock
New York
|
+$29.6M |
Top Sellers
| 1 | -$19M | |
| 2 | -$15.7M | |
| 3 | -$10.5M | |
| 4 |
Millennium Management
New York
|
-$5.55M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.52M |